Cooke & Bieler LP lessened its stake in Markel Group Inc. (NYSE:MKL – Free Report) by 3.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 32,067 shares of the insurance provider’s stock after selling 1,090 shares during the quarter. Cooke & Bieler LP’s holdings in Markel Group were worth $61,292,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the stock. Clearstead Trust LLC lifted its holdings in Markel Group by 180.0% in the second quarter. Clearstead Trust LLC now owns 14 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 9 shares during the period. Chilton Capital Management LLC purchased a new position in shares of Markel Group during the 2nd quarter valued at approximately $32,000. Ameritas Advisory Services LLC acquired a new position in shares of Markel Group in the 2nd quarter valued at $38,000. GoalVest Advisory LLC purchased a new stake in Markel Group during the third quarter worth $38,000. Finally, Hemington Wealth Management boosted its holdings in Markel Group by 35.3% during the third quarter. Hemington Wealth Management now owns 23 shares of the insurance provider’s stock worth $43,000 after buying an additional 6 shares in the last quarter. Hedge funds and other institutional investors own 77.12% of the company’s stock.
Insider Activity at Markel Group
In related news, CEO Simon Wilson sold 75 shares of the stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $2,072.94, for a total value of $155,470.50. Following the completion of the transaction, the chief executive officer directly owned 1,770 shares of the company’s stock, valued at approximately $3,669,103.80. This represents a 4.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Steven A. Markel sold 1,330 shares of the firm’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $2,119.12, for a total value of $2,818,429.60. Following the completion of the transaction, the director owned 60,368 shares in the company, valued at $127,927,036.16. The trade was a 2.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,575 shares of company stock valued at $3,330,900 over the last quarter. 1.66% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on Markel Group
Markel Group Trading Down 1.0%
Shares of Markel Group stock opened at $2,025.71 on Monday. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.24. Markel Group Inc. has a twelve month low of $1,621.89 and a twelve month high of $2,207.59. The firm has a market capitalization of $25.54 billion, a PE ratio of 12.68 and a beta of 0.80. The firm’s 50-day moving average price is $2,105.42 and its 200 day moving average price is $2,007.68.
Markel Group (NYSE:MKL – Get Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The insurance provider reported $30.90 EPS for the quarter, topping the consensus estimate of $22.77 by $8.13. The company had revenue of $3.93 billion during the quarter, compared to analyst estimates of $3.77 billion. Markel Group had a return on equity of 7.76% and a net margin of 12.99%. On average, sell-side analysts predict that Markel Group Inc. will post 96.25 EPS for the current fiscal year.
Markel Group Profile
Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.
In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.
Read More
- Five stocks we like better than Markel Group
- Buy This Stock at 9:30 AM on MONDAY!
- What Expenses Can Be Deducted From Capital Gains Tax?
- A U.S. “birthright” claim worth trillions – activated quietly
- This stock gets a 94 out of 100
- Nvidia CEO Issues Bold Tesla Call
Want to see what other hedge funds are holding MKL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Markel Group Inc. (NYSE:MKL – Free Report).
Receive News & Ratings for Markel Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Group and related companies with MarketBeat.com's FREE daily email newsletter.
